Igc Pharma Inc (IGC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 81 | 108 | 125 | 584 | 29 |
| Cost of Goods | 54 | 94 | 99 | 538 | 13 |
| Gross Profit | 27 | 14 | 26 | 46 | 16 |
| Operating Expenses | 2,872 | 2,434 | 1,801 | 2,515 | 2,472 |
| Operating Income | -2,791 | -2,326 | -1,676 | -1,931 | -2,443 |
| Other Income | -158 | 3 | 19 | 49 | -711 |
| Pre-tax Income | -2,949 | -2,323 | -1,657 | -1,882 | -3,154 |
| Net Income Continuous | -2,949 | -2,323 | -1,657 | -1,882 | -3,154 |
| Net Income | $-2,949 | $-2,323 | $-1,657 | $-1,882 | $-3,154 |
| EPS Basic Total Ops | -0.06 | -0.06 | -0.04 | -0.05 | -0.09 |
| EPS Basic Continuous Ops | -0.07 | -0.06 | -0.04 | -0.05 | -0.08 |
| EPS Diluted Total Ops | -0.06 | -0.06 | -0.04 | -0.05 | -0.09 |
| EPS Diluted Continuous Ops | -0.07 | -0.06 | -0.04 | -0.05 | -0.08 |
| EBITDA(a) | $-2,625 | $-2,199 | $-1,568 | $-1,854 | $-2,368 |